简介:摘要目的检测肺癌患者化疗前后血清中IL-6、IL-10,较其与健康志愿者表达水平的差异,为肺癌的血清学检查和治疗提供理论依据。方法采用ELISA方法检测临床收集的确诊肺癌患者血清40例,健康志愿者血清样品20例,比较分析IL-6、IL-10水平在三组患者血清之间表达差异,进一步按照肺癌患者的癌症类型、及临床分期分别分析,比较表达的水平差异。结果肺癌患者血清IL-6水平明显高于健康志愿者,而IL-10水平显著降低;化疗后IL-6水平降低,IL-10水平无明显变化。肺癌患者血清中IL-6、IL-10水平与癌症病理类型没有明显的差异。结论肺癌患者血清中IL-6水平升高、IL-10水平下降,化疗后IL-6水平降低,IL-10水平无明显变化,监测IL-6表达水平可作为肺癌化疗疗效指标。
简介:Objective:Tostudytheeffectofthreedifferentmethodssuchasmedicine,acupunctureandlaseracupunctureonthelevelsofinterleukin2(IL-2),interleukin6(IL-6)andtransforminggrowthfactor-β1(TGF-β1)inrat’sserumwithchronicatrophicgastritis.Methods:9ratswererandomlyselectedfrom60ratsasnormalcontrolgroup,andtheotherratswereusedtoreplicatetheanimalmodelofchronicatrophicgastritiswithcomprehensivemethod,5ratswererandomlyinspectedatthe8thweekintheprocessofcreatingmodelforgastricmucosapathologicalexamination;whengastricmucosashowsCAGsymptomssuchasvariousdegreeofcongestion,bleeding,atrophy,metaplasia,themodelratswererandomlydividedintomodelgroup,medicinegroup,acupuncturegroupandlaseracupuncturegroup.TheratsofmedicinegroupwerechronicallyadministeredwithyanshenjianweicapsuleandKangfuxinLiquid;thegroupsofacupunctureandlaseracupunctureselectedZusanliacupunctureasacupuncturepoints,afterthetreatmentfor14d,bloodwasremoved,doubleantibodysandwichenzymelinkedimmunosorbentassay(ELISA)wasusedtodetectthelevelsofIL-2,IL-6andTGF-β1inserum.Results:Comparedwithnormalgroup,thecontentsofIL-2,IL-6andTGF-β1inserumofmodelratsincreased(P<0.05orP<0.01).Medicine,acupunctureandlaseracupuncturecouldreducethecontentsofIL-2,IL-6andTGF-β1,IL-2inserumofthemedicinegroupandlaseracupuncturegroupwassignificantlydecreased(P<0.05);IL-6inacupuncturegroupandlaseracupuncturegroupweresignificantlydecreased(P<0.05orP<0.01);andthemostsignificantislaseracupuncturegroup(P<0.01).Medicine,acupunctureandlaseracupuncturecouldsignificantlyreduceTGF-β1contentinserum(P<0.05orP<0.01),andtheparticularlysignificantwaslaseracupuncture(P<0.01).Conclusion:Laseracupuncturehasthefunctionofreducingtheinflammatoryresponseandadjustingimmunefunction.ItcaneffectivelyreducetheexpressionlevelofIL-2,IL-6andTGF-β1inserumofratswithchronicat
简介:摘要目的观察喉癌(CarcinomaofLarynx)患者白细胞介素-2、6(Interleukin-2、6,IL-2、6)水平及手术前后的变化。方法67例喉癌患者与62例健康对照组进行比较,观察其手术前后IL-2、6的变化。结果67例喉癌患者IL-2、IL-6血清水平与对照组比较有显著性差异(P<0.01)。喉癌组Ⅰ、Ⅱ期与Ⅲ、Ⅳ期组间IL-2、IL-6血清水平比较有显著性差异(P<0.05)。术后2周及1月IL-2、IL-6血清水平变化无显著性差异(P>0.05),IL-2与对照组比较亦无差异(P>0.05)。结论喉癌患者血清IL-2、6发生显著的变化,手术治疗对喉癌患者IL-2、IL-6的水平有明显干预作用。
简介:<正>Asoneofthemostcharacterizedcytokines,interleukin3(IL-3)iswellknownforitssurvivaleffectonbothprogenitorsandmaturebloodcells.Althoughwiththeextensivestudies,thesignalingpathwaysandunderlyingmechanismleadingtosurvivalresponsesofIL-3stillarenotcompletelyunderstood.Recently,anapoptoticgeneticpathwayofC.eleganswassuggestedtobeevolutionallyconservedinthatcontrolsthecytokine-dependentanti-apoptoticresponsesinmammalianhematopoieticcelllineages.Amongthispathway,Ces-2isknowntobethefirstdeathspecificationgeneintheC.eleganspathwayandencodesabZIPfamilytranscriptionalfactorthatsharesthesameDNArecognitionsequencewithanoncoprotein,
简介:曹思源职务:北京思源社会科学研究中心总裁、思源兼并与破产咨询事务所所长入选理由:1988午10月下海创建民办研究机构;先后为深圳、海南、沈阳、沙市、景德镇、北海、淮阴等地方政府和北京、上海、浙江、山西运城等法院以及100多家企业提供有关破产程序、兼并收购、招商引资、企业重组和股份制改革等方面的政策法律咨询与中介服务,人称“曹破产”。